Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 15178360)

1.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW.

Eur J Pharmacol. 2004 May 25;492(2-3):159-67.

PMID:
15178360
2.

Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.

Glick SD, Maisonneuve IM, Kitchen BA, Fleck MW.

Eur J Pharmacol. 2002 Mar 1;438(1-2):99-105.

PMID:
11906717
3.

Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.

Glick SD, Sell EM, Maisonneuve IM.

Eur J Pharmacol. 2008 Dec 3;599(1-3):91-5. doi: 10.1016/j.ejphar.2008.09.038. Epub 2008 Oct 1.

4.

18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.

Glick SD, Ramirez RL, Livi JM, Maisonneuve IM.

Eur J Pharmacol. 2006 May 10;537(1-3):94-8. Epub 2006 Mar 24.

PMID:
16626688
5.

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.

Kuehne ME, He L, Jokiel PA, Pace CJ, Fleck MW, Maisonneuve IM, Glick SD, Bidlack JM.

J Med Chem. 2003 Jun 19;46(13):2716-30.

PMID:
12801235
6.

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.

Maisonneuve IM, Glick SD.

Pharmacol Biochem Behav. 2003 Jun;75(3):607-18.

PMID:
12895678
7.

Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors.

Glick SD, Maisonneuve IM, Kitchen BA.

Eur J Pharmacol. 2002 Jul 19;448(2-3):185-91.

PMID:
12144940
8.

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.

Glick SD, Sell EM, McCallum SE, Maisonneuve IM.

Eur J Pharmacol. 2011 Nov 1;669(1-3):71-5. doi: 10.1016/j.ejphar.2011.08.001. Epub 2011 Aug 19.

9.

Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?

Taraschenko OD, Panchal V, Maisonneuve IM, Glick SD.

Eur J Pharmacol. 2005 Apr 25;513(3):207-18. Epub 2005 Apr 14.

PMID:
15862802
10.

α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.

McCallum SE, Cowe MA, Lewis SW, Glick SD.

Neuropharmacology. 2012 Sep;63(3):434-40. doi: 10.1016/j.neuropharm.2012.04.015. Epub 2012 Apr 26.

11.

Development of novel medications for drug addiction. The legacy of an African shrub.

Glick SD, Maisonneuve IM.

Ann N Y Acad Sci. 2000;909:88-103.

PMID:
10911925
12.

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.

Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH.

Brain Res. 1996 May 6;719(1-2):29-35.

PMID:
8782860
13.

Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.

Rho B, Glick SD.

Neuroreport. 1998 May 11;9(7):1283-5.

PMID:
9631413
14.
15.

18-MC reduces methamphetamine and nicotine self-administration in rats.

Glick SD, Maisonneuve IM, Dickinson HA.

Neuroreport. 2000 Jun 26;11(9):2013-5.

PMID:
10884062
16.

Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.

Maisonneuve IM, Glick SD.

Eur J Pharmacol. 1999 Oct 21;383(1):15-21.

PMID:
10556676
17.

Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.

Panchal V, Taraschenko OD, Maisonneuve IM, Glick SD.

Eur J Pharmacol. 2005 Nov 21;525(1-3):98-104. Epub 2005 Nov 10.

PMID:
16289028
18.

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.

Glick SD, Maisonneuve IM, Szumlinski KK.

Ann N Y Acad Sci. 2000 Sep;914:369-86.

PMID:
11085336
19.

Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.

Silva EM, Cirne-Santos CC, Frugulhetti IC, Galvão-Castro B, Saraiva EM, Kuehne ME, Bou-Habib DC.

Planta Med. 2004 Sep;70(9):808-12.

PMID:
15386189
20.

Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats.

Löscher W, Potschka H, Wlaź P, Danysz W, Parsons CG.

Eur J Pharmacol. 2003 Apr 11;466(1-2):99-111.

PMID:
12679146
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk